Jennifer R. Pyle

Selective Estrogen Receptor Modulators and Phytoestrogens

V. Jordan, Roshani R. Patel, T. Oseni, 2008, Planta medica.

Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors.

J. Fargnoli, F. Zhu, Tianyu Li, 2010, European journal of cancer.

Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen

Tudor I. Oprea, Bin Chen, T. Oprea, 2007, Molecular Cancer Therapeutics.

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

V. Jordan, J. Lewis-Wambi, Helen R. Kim, 2008, Breast Cancer Research.

Emerging principles for the development of resistance to antihormonal therapy: Implications for the clinical utility of fulvestrant

Tianyu Li, E. Ariazi, V. Jordan, 2006, The Journal of Steroid Biochemistry and Molecular Biology.

Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase

G. Prendergast, A. P. Soler, Courtney M. Smith, 2011, Cancer biology & therapy.